Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Medtronic Inc. Cardiac Rhythm Disease Managment
WARNING LETTER
•Medtronic Inc. Cardiac Rhythm Disease Managment•August 6, 2009

Medtronic Inc. Cardiac Rhythm Disease Managment – FDA Warning Letter, Aug 6, 2009

Record Details

The FDA issued a Warning Letter to Medtronic's Cardiac Rhythm Disease Management business unit following an inspection from June 8 to August 6, 2009, which found their implantable pacemakers and leads to be adulterated under 21 U.S.C. § 351(h). The inspection revealed non-conformity with Quality System (QS) regulation (21 CFR Part 820).

Key violations included: 1. **Failure to establish and maintain adequate corrective and preventive action (CAPA) procedures (21 CFR 820.100(a)(2 and 3))**: Medtronic failed to consistently handle investigations and identify actions for nonconformities. Specifically, Field Product Impact Reports (FPIRs) and field corrective actions for recurring device failures (Sigma and Kappa pacemakers) were not uniformly completed. CAPAs were closed despite predicted clinical event numbers being exceeded, and new CAPAs/recalls were significantly delayed, leading to many more failures than predicted. 2. **Failure to follow procedures for design change validation/verification (21 CFR 820.30(i))**: Measurement equipment for component evaluation did not meet accuracy requirements, leading to reliance solely on supplier measurements. Component qualification plans lacked complete tests, acceptance criteria, and were not fully followed regarding testing percentages. 3. **Failure to implement CAPA documentation procedures (21 CFR 820.1

Company
Medtronic Inc. Cardiac Rhythm Disease Managment
Inspection date
August 6, 2009
Product type
Devices
Office
Minneapolis District Office
People
  • Charles Becoat (Director W.)
  • Timothy D. Samsel
View Company Profile

ID · 3b2ad749-768d-40f5-ba2a-829827f4b39d

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(a)(2 and 3)21 CFR 820.30(i)21 CFR 820.100(b)21 CFR 820.30(g)21 CFR 820.4021 CFR 820.50(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medtronic Inc. Cardiac Rhythm Disease Managment
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.